NASDAQ: FONR
- Last Close 15.91
- Sector Healthcare
- Industry Diagnostics & Research
- Investment Style Small Value
- Day Range 15.80 – 15.98
- Year Range 13.28 – 19.00
- Market Cap 106.0505 Mil
- Volume / Avg 2,122.0 / 7,964.1
- Price / Sales 1.08
- Price / Book 0.67
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis FONR
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile FONR
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue. The company's areas of operations are principally in the United States. It also exports to the United Arab Emirates, England, and Germany.
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Fonar Corp
XNAS: FONR
| Lantheus Holdings Inc
XNAS: LNTH
| AFP Imaging Corp
PINX: IWKS
| Electromed Inc
XASE: ELMD
| |
Price
| 15.91 | 64.62 | — | 10.32 |
Currency
| USD | USD | — | USD |
Change
| −$0.05 (0.31%) | +$2.80 (4.53%) | — | −$0.43 (4.00%) |
Market Cap
| 106.05 Mil | 4.42 Bil | — | 88.29 Mil |
Industry
| Diagnostics & Research | Drug Manufacturers - Specialty & Generic | Diagnostics & Research | Medical Devices |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Fonar Corp Stock
No. FONR does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
FONR’s market cap is 106.05 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
FONR’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
FONR’s price/sales is 1.08.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
FONR’s price/forward earnings is 10.75.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
FONR’s price/book is 0.67.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See FONR’s valuation ratios compared to the Market Index.
FONR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare FONR’s historical performance against its industry peers and the overall market.